verified SJR 0,818 · Q2 • database Scopus / SJR & Web of Science indexed

United States · Wiley-Liss Inc.

workspace_premium Q2 — Medicine (miscellaneous) lock_open Open Access

Journal of Clinical Apheresis

Journal of Clinical Apheresis is a journal indexed in SJR in Medicine (miscellaneous) and Hematology with an H index of 54. It has a price of 2750 €. It has an SJR impact factor of 0,818 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,818.

ISSN: 0733-2459

Publisher: Wiley-Liss Inc.

Category: Medicine (miscellaneous)

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,818 Q2

H-index 54

Acceptance rate pie_chart

31%

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

2.750 € Open Access

Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,818

H-index

Docs (year)

Docs 3y

247

Total refs

1323

Cites 3y

511

Citable 3y

226

Cites/Doc 2y

2.61

Ref/Doc

21.69

Immediate OA

2750 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Bacterial decontamination of blood stem cell apheresis products

VEGF levels in patients with peripheral arterial occlusive disease receiving LDL-apheresis

Development of an in vitro miniature model to simulate immunoadsorption in patients with systemic lupus erythematosus

Determining factors for the outcome of peripheral blood progenitor cells harvests

Conventional apheresis therapies: A review

Complications of donor apheresis

Comparative study of plateletpheresis using Baxter CS 3000 plus and Haemonetics MCS 3P

Collection of platelets and peripheral progenitor cells with the Fresenius AS.TEC 204 blood cell separator

Collection of a mobilized peripheral blood apheresis product from a patient with mucopolysaccharidosis type VII and subsequent CD34+ cell isolation

Cholesterol biosynthesis in normocholesterolemic patients after cholesterol removal by plasmapheresis

Characteristics of 73 patients, 1984-1993, treated by plasma exchange for Guillain-Barre syndrome

Calculated platelet dose: Is it useful in clinical practice?

SHOW MORE ARTICLES

Bacterial detection in platelet components and the rationale for pathogen inactivation: A blood center perspective.

A case of thrombocytopoenic thrombotic purpura preceding onset of systemic lupus erythematosus

Autologous peripheral blood stem cell collections in children weighing less than 10 Kg with solid tumors: Experience of a single center

Augmented autologous transfusions in major reconstructive spine surgery

Assessment of complement activation during membrane-based plasmapheresis procedures

Apheresis medicine state of the art in 2010: American Society for Apheresis fifth special edition of the Journal of Clinical Apheresis

Anti-GM1, anti-central myelin proteins, and anti-cardiolipin autoantibodies during plasma-exchange in Guillain-Barre syndrome (GBS)

An overview of therapeutic apheresis in pediatrics

An approach to evidence-based therapeutic apheresis

Adsorptive monocyte-granulocytapheresis (M-GCAP) for refractory Crohn's disease

Adsorption of anti-annexin V using dextran sulfate bound cellulose beads

Acute thrombotic thrombocytopenic purpura following orthopedic surgery

FAQs

Journal of Clinical Apheresis has an SJR of 0,818 (best quartile Q2) in the CountryOfPapers database.

Immediate OA APC is 2750 EUR. Non-OA / submission fee is 0 EUR.

The acceptance rate recorded for Journal of Clinical Apheresis is 31%.

Journal of Clinical Apheresis

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Journal of Clinical Apheresis?

What is the APC / publication cost?

What is the acceptance rate?